VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
The VOICE Study, sponsored by Neuralink Corp, represents a pioneering effort in the development of a robotically implanted brain-computer interface (BCI) designed to restore communication in adults with severe speech impairments due to neurological conditions such as ALS, PLS, stroke, and spinal cord injuries. The potential market for such technology is significant, given the increasing prevalence of neurological disorders and the growing demand for innovative solutions to enhance quality of life for affected individuals. Competitive analysis indicates that while there are existing communication aids, the unique approach of a direct neural interface may position Neuralink favorably in the market. Diligence considerations should focus on regulatory pathways, particularly FDA device approval processes, and the ethical implications of invasive neural technologies.
Indication: Tetraplegia/Tetraparesis
Modality: medical device
Target: Brain-Computer Interface (BCI) technology aimed at restoring communication in individuals with severe speech production impairment through direct neural interfacing.
Sponsor: Neuralink Corp
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jun 25, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Brain-Computer Interface (BCI) technology aimed at restoring communication in individuals with severe speech production impairment through direct neural interfacing.
View original source fields
Condition raw: Tetraplegia/Tetraparesis, Quadriplegia, Cervical Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Quadriplegia/Tetraplegia, Tetraplegic; Paralysis, Stroke
Condition normalized: Tetraplegia/Tetraparesis, Quadriplegia, Cervical Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Quadriplegia/Tetraplegia, Tetraplegic; Paralysis, Stroke
Modality raw: medical device
Modality normalized: medical device
Target raw: Brain-Computer Interface (BCI) technology aimed at restoring communication in individuals with severe speech production impairment through direct neural interfacing.
Target normalized: Brain-Computer Interface (BCI) technology aimed at restoring communication in individuals with severe speech production impairment through direct neural interfacing.